Loss of CHTF18-RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors. [PDF]
Buckley-Benbow L +4 more
europepmc +1 more source
Interpretable QSAR and Complementary Docking for PARP1 Inhibitor Prioritization: Reliability Stratification and Near-Domain Screening. [PDF]
Elsayad AM, Elsayad KA.
europepmc +1 more source
The Expanding Landscape of ADP-Ribosylation: Protein, DNA, RNA, and Mitochondrial Regulation. [PDF]
Sin YC, Zhao L.
europepmc +1 more source
NAD<sup>+</sup>‒circadian rhythm coupling in dementia. [PDF]
Zhang SQ +7 more
europepmc +1 more source
New insights into Rett syndrome pathogenesis: defining the role of MEPC2 in DNA damage. [PDF]
Mansooralavi N, Lowry WE.
europepmc +1 more source
PARP inhibitors target cellular energy metabolism: Mechanisms of action and clinical implications. [PDF]
Li J +6 more
europepmc +1 more source
In Vitro Evaluation of PARP1 Inhibitor Olaparib-Cyanine Dye Conjugate for the Treatment of Glioblastoma. [PDF]
Dumo C +8 more
europepmc +1 more source
SIRT7-mediated deacetylation of XRCC6 at lysine 591 drives breast cancer progression. [PDF]
Yin J +15 more
europepmc +1 more source
Lactylome Reprogramming Mediates Therapeutic Response and Adaptation to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. [PDF]
Peng P +13 more
europepmc +1 more source

